Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

CYP7B1: novel mutations and magnetic resonance spectroscopy abnormalities in hereditary spastic paraplegia type 5A

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Does continuous electroencephalography influence therapeutic decisions in neurocritical care?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Transcranial low-frequency pulsating electromagnetic fields (T-PEMF) as post-concussion syndrome treatment

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Effect and efficacy of lifestyle interventions as secondary prevention

    Publikation: Bidrag til tidsskriftReviewpeer review

  4. Prevalence and risk of occult cancer in stroke

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Circulating nociceptin and CGRP in medication-overuse headache

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. TDP-43-specific Autoantibody Decline in Patients With Amyotrophic Lateral Sclerosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Complement Profiles in Patients with Amyotrophic Lateral Sclerosis: A Prospective Observational Cohort Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Paroxysmal Cranial Dyskinesia and Nail-Patella Syndrome Caused by a Novel Variant in the LMX1B Gene

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Blood pressure and brain injury in cardiac surgery: a secondary analysis of a randomized trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

UNLABELLED: The SPG5A subtype of Hereditary Spastic Paraplegia (HSP) is a rare autosomal recessive neurodegenerative disorder caused by mutations in the CYP7B1 gene, which encodes a steroid cytochrome P450 7α-hydroxylase. This enzyme provides the primary metabolic route for neurosteroids. Clinically, SPG5A has been characterized as a pure form of HSP with a variable age of onset, but recently a broader spectrum of phenotypes has been described.

OBJECTIVE: This study characterizes four unrelated SPG5A patients through clinical evaluation.

METHODS: The investigations included blood biochemistry, electrophysiology, brain MRI and MR spectroscopy.

RESULTS: One patient had saccadic pursuit eye movements in addition to a pure HSP phenotype. Motor evoked potential (MEP) examinations revealed prolonged central conduction time. MRI of the brain showed white matter hyperintensities (WMH) in one patient. MRS showed elevated mI/Cr ratio in white matter in two patients; in the one patient with WMH and in one patient with normal MRI. Four novel mutations were identified; one frameshift (c.509 delT p.L170fs), one premature stop codon (c.334 C>T p.R112X), one amino acid changing (c.440 G>A p.G147D) and one duplication (c.945_947 dupGGC p.A316AA).

CONCLUSION: SPG5A could be characterized as a predominantly pure HSP. MRS showing elevated mI/Cr ratio in the white matter may be indicative of SPG5A.

OriginalsprogEngelsk
TidsskriftActa Neurologica Scandinavica
Vol/bind129
Udgave nummer5
Sider (fra-til)330-4
Antal sider5
ISSN0001-6314
DOI
StatusUdgivet - maj 2014

ID: 44892458